Jaba Tkemaladze
The aging process is driven by parallel accumulation of damage across multiple molecular “counters”—telomeric (#2), centriolar (#1), mitochondrial (#3), epigenetic (#4), and proteostatic (#5). The Multi-Counter Organismal Aging (MCOA) framework posits that no single counter universally limits lifespan; instead, their relative contribution depends on tissue context. Here we extend MCOA with three interconnected principles and introduce piRNA-mediated regulation as a potential sixth counter (#6). First, we formalize context-dependent counter prioritization through a nonlinear differential equation incorporating damage clearance. Second, we provide an updated atlas of tissue-specific winner counters, demonstrating that hematopoietic stem cells (HSCs) can switch from telomeric (#2) to proteostatic (#5) dominance under inflammatory stress, as observed in VEXAS syndrome . Third, we propose the Master-Counter Hypothesis: organismal aging is governed by winner counters operating within tissue-specific stem cell compartments. Using a meta-analysis of 28,325 participants (Global Epigenetic Age Consortium, The Lancet Healthy Longevity, 2025), we demonstrate that GrimAge epigenetic age acceleration (EAA) has the strongest association with frailty (β=0.11, 95% CI 0.06–0.15) and serves as an integrative marker of the master counter . Finally, we introduce piRNA-mediated regulation as a potential counter #6: circulating piRNAs predict 2-year survival with AUC up to 0.92 in older adults, and lower piRNA levels associate with longer survival . Nine piRNAs were identified as potential therapeutic targets. We present falsifiable predictions, including tissue-specific proteostasis interventions and piRNA-targeted therapies.